Friday, April 19, 2024
4/19/2024
ABSTRACT When humans are exposed to a substance that causes an immune response, to protect the itself, the body generates antibodies. There is very little understood about the role of chemokines in regulating the extent of the immune response, as measured by antibody titers and types of antibodies that are made. We have found that C-C chemokine receptor 7 regulates the antibody titers by controlling the localization of different populations of immune cells to the bone marrow. In this proposal our goal is to better understand the molecular mechanisms that are employed by immune T cells to respond to C-C chemokine receptor 7 activation that regulate the targeting of T cells to the bone marrow where they regulate the isotype switching and antibody production by immune cells. Our study is important since these antibodies protect the host when he or she is exposed to the same substance during a secondary immune response. We hypothesize that CCR7 regulates the migration of memory T, and regulatory T cells to the bone marrow to limit the activation of B cells during an adaptive immune response. With the knowledge we gain we will determine if redirection of the T cells can be applied to inhibit excessive immune responses observed during autoimmune diseases.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
